BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 11196347)

  • 21. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.
    Demarin V; Podobnik SS; Storga-Tomic D; Kay G
    Drugs Exp Clin Res; 2004; 30(1):27-33. PubMed ID: 15134388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
    Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
    Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analytic study on EEG features of aging with/without psychiatric disorders: focussing at the alterations in the EEGs of the healthy, depressive and demented elderlies].
    Saito N
    Seishin Shinkeigaku Zasshi; 1995; 97(10):801-24. PubMed ID: 8552725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative EEG in patients with presenile and senile dementia of the Alzheimer type.
    Miyauchi T; Hagimoto H; Ishii M; Endo S; Tanaka K; Kajiwara S; Endo K; Kajiwara A; Kosaka K
    Acta Neurol Scand; 1994 Jan; 89(1):56-64. PubMed ID: 8178630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of felodipine in hypertensive patients with mild cerebral cognition disorders in a randomized double-blind study].
    Lehrl S; Grässel E; Eicke C
    Dtsch Med Wochenschr; 2000 Nov; 125(45):1350-5. PubMed ID: 11109422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia.
    Villardita C; Parini J; Grioli S; Quattropani M; Lomeo C; Scapagnini U
    J Neural Transm Suppl; 1987; 24():293-8. PubMed ID: 3479527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
    Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial.
    Kirste S; Treier M; Wehrle SJ; Becker G; Abdel-Tawab M; Gerbeth K; Hug MJ; Lubrich B; Grosu AL; Momm F
    Cancer; 2011 Aug; 117(16):3788-95. PubMed ID: 21287538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
    Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
    Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration.
    Muresanu DF; Alvarez XA; Moessler H; Buia M; Stan A; Pintea D; Moldovan F; Popescu BO
    J Neurol Sci; 2008 Apr; 267(1-2):112-9. PubMed ID: 18048059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [EEG background activity in patients with dementia of the Alzheimer type--with special reference to analysis by t-statistic significance probability mapping (SPM) in Alzheimer's disease and senile dementia].
    Miyauchi T; Hagimoto H; Saito T; Endo K; Ishii M; Yamaguchi T; Kajiwara A; Matsushita M
    Seishin Shinkeigaku Zasshi; 1989; 91(4):244-59. PubMed ID: 2798586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
    Martucci N; Manna V; Agnoli A
    Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.